Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by amorakon Sep 04, 2007 9:38am

418 Views

Post# 13338254

RE: What the ??? Repricings of Debt news

I don't care how much they fix this financing, it was rape and pillage from the get-go. Your question is interesting, TheFix14. How could a price be set when it's impossible to know how many shares will be outstanding? At least it appears as though nobody could know. Even the thought of a 14% interest rate is astonishing. DM must have been star-struck sitting in the Big-Boyz offices when he set this up, pizzing with the big dogs now, I am, I am, he must have thought.

Bullboard Posts

Understanding tax loss season and the “Santa Claus rally”